简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
Latest
07:49
【H WORLD-S (01179.HK): Prices RMB 3.35 Billion Senior Notes, 2.25% Due 2031】On 10 September 2026, H WORLD-S (01179.HK) announced the pricing of RMB 3.35 billion senior unsecured notes, comprising 2.25% notes due 2031, offered to non-US persons offshore under Regulation S. The offering is expected to close on or around 16 September 2026, with net proceeds for general corporate purposes and the notes expected to be listed on the Hong Kong Stock Exchange.
Tag:
H WORLD-S
01179.HK
Bond Issuance
Share:
07:41
【HUA LIEN INT'L (00969.HK): Independent Non-Executive Director Shi Zhu Resumes Duties, Effective 9 September 2026】On 9 September 2026, HUA LIEN INT'L (00969.HK) announced that Mr. Shi Zhu, the independent non-executive director suspended since April 2025 following the potential irregularities investigation at Ding Shi Capital (00804.HK), will resume his duties as independent non-executive director and his committee positions from 9 September 2026, after the Board and nomination committee concluded there are insufficient grounds to question his integrity, character or suitability.
Tag:
HUA LIEN INTL
00969.HK
Share:
07:35
【LEE'S PHARM (00950.HK): In-Licenses PARP1 Inhibitor OC-3 from 1cBio for Development and Commercialization in Greater China and Southeast Asia】On 9 September 2026, LEE'S PHARM (00950.HK) announced an exclusive license agreement with US-based 1cBio for OC-3, a preclinical-stage next-generation selective PARP1 inhibitor for homologous recombination repair-deficient cancers, covering development, manufacture and commercialization in Greater China and certain Southeast Asian countries. Lee's Pharmaceutical (Hong Kong) will be responsible for GLP safety studies and manufacturing.
Tag:
LEES PHARM
00950.HK
Strategic Partnership
Share:
07:28
【DL HOLDINGS GP (01709.HK): Grants 42 Million Award Shares to 14 Participants, Funded by Market Purchases with No Dilution】On 9 September 2026, DL HOLDINGS GP (01709.HK) announced the grant of an aggregate of 42 million award shares to 14 eligible participants under its 2025 Restricted Share Award Scheme, fully funded by market purchases by the trustee with no new share issuance or dilution. Group A's 6 million shares vest immediately, while Group B's 36 million shares vest after 18 months.
Tag:
DL HOLDINGS GP
01709.HK
Share Award
Share:
07:23
【CHINA ENV TEC (00646.HK): Appoints Shu Zhongwen as Executive Director and Managing Director; Professor Geng Lin as Independent Non-Executive Director】On 9 September 2026, CHINA ENV TEC (00646.HK) announced the appointment of Mr. Shu Zhongwen as executive director and managing director, and Professor Geng Lin as independent non-executive director and member of the audit, remuneration and nomination committees, effective 9 September 2026.
Tag:
CHINA ENV TEC
00646.HK
Board Change
Share:
07:20
【YIDU TECH (02158.HK): Wins Bid for Shanghai Pulmonary Hospital Data Platform Localization Upgrade Project Worth Approximately RMB 3.57 Million】On 9 September 2026, YIDU TECH (02158.HK) announced that its affiliate Yidu Cloud (Beijing) has won the bid for the Shanghai Pulmonary Hospital data platform localization upgrade project, with a total value of approximately RMB 3.57 million, as published on the National Public Resources Trading Platform (Shanghai).
Tag:
YIDU TECH
02158.HK
Contract Win
Share:
22:07
【BOAN BIOTECH (06955.HK): Enters into Supplementary Agreement to Finance Lease, Confirming RMB 75 Million Purchase Price Unchanged】On 9 September 2026, Shandong Boan Biotechnology Co., Ltd. (06955.HK) announced that it had entered into a supplementary agreement with Industrial Financial Leasing in respect of its finance lease agreement: after adjusting certain machinery and equipment items comprising the leased assets, the parties confirmed that the purchase price of RMB 75.00 million was determined with reference to the book value of the adjusted leased assets as of 31 August 2026 (approximately RMB 100.61 million), with the purchase price and the transaction's classification remaining unchanged.
Tag:
BOAN BIOTECH
06955.HK
Finance Lease
Share:
22:04
【MINSHENG EDU (01569.HK): HKIAC Issues Final Award on Option over 49% of Lide International Education, Exit Price of RMB 2.18 Billion】On 9 September 2026, Minsheng Education Group Company Limited (01569.HK) announced receipt of a final HKIAC award dated 8 September 2026 ordering specific performance of the sale of a 49% interest in Lide International Education Group under a 2018 SPA at an exit price of RMB 2,180,735,576.50 plus costs and interest, with completion subject to resolution of share encumbrances; the company has sought to set aside the partial award before the Hong Kong High Court since July 2026.
Tag:
MINSHENG EDU
01569.HK
Litigation
Share:
21:56
【JXR (01951.HK): Proposes to Develop Translational Medicine Platform Focusing on Women's Health, Signs Research MOU with Academician Ji Weizhi】On 9 September 2026, Jinxin Fertility Group Limited (01951.HK) announced in a voluntary announcement its proposal to develop a translational medicine platform focusing on women's health (initially targeting ovarian ageing and diminished ovarian reserve), leveraging its existing clinical and reproductive medicine capabilities; it has signed a research MOU with academician Professor Ji Weizhi and a framework agreement with a research animal resources partner, with the platform at an early stage and no material near-term impact expected.
Tag:
JXR
01951.HK
strategic cooperation
Share:
21:54
【JNBY (03306.HK): Independent Non-executive Director Lam Hiu Po Retires; Wong Shun Tak Appointed Audit Committee Chairman】On 9 September 2026, JNBY Design Limited (03306.HK) announced that independent non-executive director Mr. Lam Hiu Po will not seek re-election at the annual general meeting on 2 October 2026 and will retire as INED, audit committee chairman and remuneration committee member, with Mr. Wong Shun Tak to take over as audit committee chairman and remuneration committee member with effect from the conclusion of the AGM.
Tag:
JNBY
03306.HK
Board Change
Share:
21:52
【QINGDA ORIENTAL (08115.HK): Board Lot Size Changed from 4,000 to 500 H Shares, Effective 30 September】On 9 September 2026, Qingda Oriental Group Co., Ltd. (08115.HK) announced that the board lot size of its H shares would be changed from 4,000 to 500 shares with effect from 30 September 2026; based on the closing price of HKD 5.10, the market value per lot would fall from approximately HKD 20,400 to HKD 2,550, which the company said would lower the investment threshold, facilitate trading and improve liquidity.
Tag:
QINGDA ORIENTAL
08115.HK
board lot size
Share:
21:50
【S ROBOT EDU (08206.HK): Appoints Grand Finance Capital as Independent Financial Adviser; Trading Remains Suspended】On 9 September 2026, Shen Tong Robot Education Group Limited (08206.HK) announced the appointment of Grand Finance Capital Limited as independent financial adviser, upon approval of the independent board committee, to advise independent shareholders on the debt capitalisation, subscription agreement and whitewash waiver; the company's shares have been suspended since 14 October 2025 and remain suspended pending fulfilment of the resumption guidance.
Tag:
S ROBOT EDU
08206.HK
Suspension & Resumption
Share:
21:48
【BAIYING HOLDING (08525.HK): All Resumption Guidance Fulfilled, Resumption of Trading Applied for 10 September】On 9 September 2026, Baiying Holdings Group Limited (08525.HK) announced that it had fulfilled all GEM resumption guidance (demonstrating compliance with Rule 17.26 and informing the market of material information) and applied for resumption of trading from 10 September 2026; the group operates finance leasing, financial information services (SaaS system) and paper products trading, and has obtained RMB 400 million of bank facilities without controlling shareholder guarantees.
Tag:
BAIYING HOLDING
08525.HK
resumption guidance
Share:
21:45
【YZYBIO-B (02496.HK): Proposes Issuing 35.59 Million Domestic Shares to Three Directors at RMB 2.43 Each, Raising about RMB 83 Million; Whitewash Waiver Sought and Trading to Resume】On 9 September 2026, Wuhan YZY Biopharma Co., Ltd. (02496.HK) announced a proposed allotment of 35,592,400 domestic shares to three director-subscribers at RMB 2.43 per share for net proceeds of approximately RMB 83 million, with 90% to repay bank borrowings; as the subscribers' and concert parties' aggregate stake would rise to approximately 52.17%, a whitewash waiver is being sought, and trading in the H shares is scheduled to resume on 10 September 2026.
Tag:
YZYBIO-B
02496.HK
Share Issue
Share:
19:52
【DCWT (03768.HK): Controlling Shareholder's Shares in Company Remain under Judicial Freeze for Three Years】On 9 September 2026, Kunming Dianchi Water Treatment Co., Ltd. (03768.HK) disclosed in an inside information announcement that shares held by controlling shareholder Kunming Dianchi Investment in the company remain under judicial freeze for three years (9 September 2026 to 8 September 2029) within RMB 123,530,242.28, following an assistance enforcement notice from the Panlong District People's Court; Kunming Dianchi Investment holds 37.79% of the company's domestic shares, all subject to pledges and/or freezes, and the company said its normal operations are unaffected.
Tag:
DCWT
03768.HK
Judicial Freeze
Share:
19:46
【ADWAY (06189.HK): Executive Director Liu Zhenyu Appointed as Chief Executive Officer】On 9 September 2026, Guangdong ADWAY Construction (Group) Holdings Company Limited (06189.HK) announced the appointment of executive director Mr. Liu Zhenyu as chief executive officer with effect from 7 September 2026; Mr. Liu, aged 53, joined the group on 27 August 2026 and previously served in management roles at China Construction Second Engineering Bureau and several other companies, under a three-year service agreement with annual remuneration of RMB 80,000 (before tax).
Tag:
ADWAY
06189.HK
Board Change
Appointment
Share:
19:33
【CH ENERGY ENG (03996.HK): Subsidiary Northwest Electric Power Design Institute Wins RMB 6.44 Billion EPC Contract for Zhaoshipan Power Plant Phase II】On 9 September 2026, China Energy Engineering Corporation Limited (03996.HK) announced that its subsidiary Northwest Electric Power Design Institute had won the EPC contract for the Phase II of the Shaanxi Investment Zhaoshipan Power Plant (2×1000MW units) with a contract value of RMB 6.44 billion, covering two 1,000 MW ultra-supercritical coal-fired units and environmental facilities with a construction period of about 31 months; the contract has not yet been formally signed.
Tag:
CH ENERGY ENG
03996.HK
won the bid
Share:
19:25
【HBM HOLDINGS-B (02142.HK): Partner Solstice Oncology Closes USD 225 Million Series A Financing】On 9 September 2026, HBM Holdings Limited (02142.HK) announced in a voluntary announcement that its partner Solstice Oncology had completed a USD 225 million Series A financing led by RA Capital Management and commenced operations; Solstice is advancing the second-generation Fc-enhanced anti-CTLA-4 antibody pruluzubartamab, with a Phase II study in MSS colon cancer expected to begin enrolment in early Q4 2026.
Tag:
HBM HOLDINGS-B
02142.HK
R&D Progress
financing
Share:
19:23
【BILIBILI-W (09626.HK): Completes USD 500 Million Convertible Notes Offering with Concurrent Hedging Repurchases and Share Placements】On 9 September 2026, Bilibili Inc. (09626.HK) announced the completion of its offering of convertible senior notes with an aggregate principal of USD 500 million due 2031 and the concurrent repurchase of approximately USD 100 million of Class Z ordinary shares; the hedging placement of borrowed shares and a secondary placement by a Tencent subsidiary were completed, while Tencent's subscription for an additional USD 200 million of notes and the related share repurchase remain subject to independent shareholders' approval at an EGM.
Tag:
BILIBILI-W
09626.HK
Bond Issuance
Share:
19:19
【ECI TECH (08013.HK): Lau Chi Yuen Resigns as Company Secretary, Chan Suet Ngan Appointed as Successor】On 9 September 2026, ECI Technology Holdings Limited (08013.HK) announced the resignation of Mr. Lau Chi Yuen as company secretary to focus on other business arrangements, with Ms. Chan Suet Ngan appointed as his successor on the same day; Ms. Chan has over 23 years of experience in accounting, finance and company secretarial matters and is a member of CPA Australia and the HKICPA.
Tag:
ECI TECH
08013.HK
Board Change
Share:
Previous
1..
8
9
10
11
12
..523
Next
523
pages total
Featured News
Overseas
Going Global Weekly: Pharma Licensing and Overseas Registrations Land in Cluster, Manufacturing Capacity Expansion in Southeast Asia Accelerates-20260911
Finance
SITOY GROUP (01023.HK): Profit Warning, Full-year Loss Attributable to Owners Expected to Narrow to HKD 110,000,000 to HKD 130,000,000
Finance
DIAGENS-B (02526.HK): Signs Three-Year Cooperation Framework Agreement with Anzhen'er on Provincial Medical Imaging AI Platform
Finance
HANSOH PHARMA (03692.HK): Small Cell Lung Cancer Product HS-20093 Included in NMPA Priority Review Procedure
Finance
UCD (01599.HK): Files with CSRC for H-share Full Circulation Involving 68,816,000 Domestic Unlisted Shares
Finance
CHOW TAI FOOK (01929.HK): Applies to Register and Proposes Issue of Panda Bonds of Up to RMB 10 Billion
Research
HK shares ETFs Daily Report: iShares Core MSCI China Index ETF Leads Alone, Up Over 1.5%, as AI and Semiconductor Names Come Under Broad Pressure — September 11, 2026
Research
Shanghai-Shenzhen Stock Connect ETFs Daily Report: Military and Communication Themes Gain Momentum; Non-Ferrous Metals Sector Plunges Collectively - 20260911
ETF
Tracker Fund Of Hong Kong (02800.HK) Falls 0.55% Intraday, AUM at HK$133.882 Billion
ETF
Ishares Ftse China A50 Etf (02823.HK) Falls 0.54% Intraday to HK$16.570
Scan QR Code
Download App
×
Share to WeChat
Open WeChat, use "Scan," and share to my Moments